These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7534266)

  • 1. Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor.
    Irani AA; Nilsson G; Ashman LK; Schwartz LB
    Immunology; 1995 Jan; 84(1):72-8. PubMed ID: 7534266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells.
    Irani AM; Nilsson G; Miettinen U; Craig SS; Ashman LK; Ishizaka T; Zsebo KM; Schwartz LB
    Blood; 1992 Dec; 80(12):3009-21. PubMed ID: 1281684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells.
    Nilsson G; Miettinen U; Ishizaka T; Ashman LK; Irani AM; Schwartz LB
    Blood; 1994 Sep; 84(5):1519-27. PubMed ID: 7520776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells.
    Du Z; Li Y; Xia H; Irani AM; Schwartz LB
    J Immunol; 1997 Jul; 159(2):838-45. PubMed ID: 9218602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells.
    Xia HZ; Du Z; Craig S; Klisch G; Noben-Trauth N; Kochan JP; Huff TH; Irani AM; Schwartz LB
    J Immunol; 1997 Sep; 159(6):2911-21. PubMed ID: 9300715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit.
    Shimizu Y; Ashman LK; Du Z; Schwartz LB
    J Immunol; 1996 May; 156(9):3443-9. PubMed ID: 8617971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors.
    Oskeritzian CA; Wang Z; Kochan JP; Grimes M; Du Z; Chang HW; Grant S; Schwartz LB
    J Immunol; 1999 Nov; 163(9):5105-15. PubMed ID: 10528217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells.
    Kirshenbaum AS; Goff JP; Kessler SW; Mican JM; Zsebo KM; Metcalfe DD
    J Immunol; 1992 Feb; 148(3):772-7. PubMed ID: 1370517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
    Rottem M; Hull G; Metcalfe DD
    Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells.
    Nilsson G; Forsberg K; Bodger MP; Ashman LK; Zsebo KM; Ishizaka T; Irani AM; Schwartz LB
    Immunology; 1993 Jun; 79(2):325-30. PubMed ID: 7688344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human mast cells developed in vitro from fetal liver cells cocultured with murine 3T3 fibroblasts.
    Irani AA; Craig SS; Nilsson G; Ishizaka T; Schwartz LB
    Immunology; 1992 Sep; 77(1):136-43. PubMed ID: 1398760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of stem cell factor on the ultrastructure of Fc epsilon RI+ cells developing in IL-3-dependent murine bone marrow-derived cell cultures.
    Rottem M; Goff JP; Albert JP; Metcalfe DD
    J Immunol; 1993 Nov; 151(9):4950-63. PubMed ID: 7691960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
    Mekori YA; Oh CK; Metcalfe DD
    J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human mast cell growth and differentiation by interferon gamma-1b.
    Kirshenbaum AS; Worobec AS; Davis TA; Goff JP; Semere T; Metcalfe DD
    Exp Hematol; 1998 Mar; 26(3):245-51. PubMed ID: 9502621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells.
    Welker P; Grabbe J; Zuberbier T; Guhl S; Henz BM
    J Invest Dermatol; 2000 Jan; 114(1):44-50. PubMed ID: 10620114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2 contributes to the intrinsic capacity of primary hematopoietic cells to respond to stem cell factor.
    Radosevic N; Winterstein D; Keller JR; Neubauer H; Pfeffer K; Linnekin D
    Exp Hematol; 2004 Feb; 32(2):149-56. PubMed ID: 15102475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
    Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
    J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of high-affinity receptor for immunoglobulin E on mast cells precedes that of tryptase during differentiation from human bone marrow-derived CD34 progenitors cultured in the presence of stem cell factor and interleukin-6.
    Shimizu Y; Suga T; Maeno T; Aoki F; Tsukagoshi H; Kawata T; Sakai K; Narita T; Takahashi T; Ishikawa S; Morishita Y; Nakajima T; Hara F; Miura T; Kurabayashi M
    Clin Exp Allergy; 2004 Jun; 34(6):917-25. PubMed ID: 15196280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cells.
    Kirshenbaum AS; Akin C; Goff JP; Metcalfe DD
    Exp Hematol; 2005 Apr; 33(4):413-21. PubMed ID: 15781331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by glucocorticoids of the interleukin-1beta-enhanced expression of the mast cell growth factor SCF.
    Da Silva CA; Kassel O; Mathieu E; Massard G; Gasser B; Frossard N
    Br J Pharmacol; 2002 Apr; 135(7):1634-40. PubMed ID: 11934803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.